Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sandesh Seth Insider Profile
4 Followers
Sandesh Seth, CEO, Director at Actinium Pharmaceuticals, holds 305.38K shares in Actinium Pharmaceuticals (Ticker: ATNM).
Sandesh Seth Actinium Pharmaceuticals (ATNM)CEO, Director
Actinium Pharmaceuticals (ATNM)
CEO, Director
Ranked #92,971 out of 98,743 Corporate Insiders
Profitable Transactions
0 out of 9 Profitable Transactions
Average Return
-37.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Sandesh Seth holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 04, 2017 - Aug 04, 2018
Return:-5.70%
The most profitable trade made by Sandesh Seth
Sandesh Seth's Trading History
List of latest transactions for each holding click on a transaction to see Sandesh Seth's performance on stock
You May Also Like
Sandesh Seth insider profile FAQ
What is the percentage of profitable transactions made by Sandesh Seth?
The percentage of profitable transactions made by Sandesh Seth is 0%.
What is the average return per transaction made by Sandesh Seth?
The average return per transaction made by Sandesh Seth is -37.90%.
What stocks does Sandesh Seth hold?
Sandesh Seth holds: ATNM stocks.
What was Sandesh Seth’s latest transaction?
Sandesh Seth latest transaction was an Uninformative Buy of ―.
What was Sandesh Seth's most profitable transaction?
Sandesh Seth’s most profitable transaction was an Informative Buy of ATNM stock on August 4, 2017. The return on the trade was -5.70%.
What is Sandesh Seth's role in Actinium Pharmaceuticals?
Sandesh Seth's role in Actinium Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.